Leading Medicine Guide

Comprehensive Cancer Center - University Cancer Center - UCC, Dresden, Prof. Dr. med. Michael Baumann

Logo
Prof. Dr. med. Michael Baumann Prof. Dr. med. Michael Baumann

Director

Prof. Dr. med. Gerhard Ehninger Prof. Dr. med. Gerhard Ehninger

UCC Board of Directors

  • Additional Staff
    • PD Dr. med. Gunnar Folprecht PD Dr. med. Gunnar Folprecht

      Director of inter-disciplinary outpatients

    • PD Dr. med. Steffen Pistorius PD Dr. med. Steffen Pistorius

      Director of inter-disciplinary outpatients

    • PD Dr. med. Daniel Zips PD Dr. med. Daniel Zips

      Director of inter-disciplinary outpatients

    • Dr. med. Monic Dawel Dr. med. Monic Dawel

    • Dr. med. Christine Hamann Dr. med. Christine Hamann

    • Dr. med. Tobias Hölscher Dr. med. Tobias Hölscher

    • Dr. med. Eva Kämmerer Dr. med. Eva Kämmerer

    • Dr. med. Stefan Ludwig Dr. med. Stefan Ludwig

    • Dr. med. Jan Mettelsiefen Dr. med. Jan Mettelsiefen

    • Dr. med. Annette Stein Dr. med. Annette Stein

Address

  • Contact Information
    Contact
    Phone: +49 (0) 351 / 458 – 4500 Fax: +49 (0) 351 / 458 – 6340
    International Contact Service
    Phone: +49 (0) 351 / 458 – 4500
    Did you find your medical expert? Please let the doctor know that you have been recommended by Leading Medicine Guide.

University Hospital Carl Gustav Carus Dresden
University Cancer Center - UCC

Prof. Dr. med. Michael Baumann
Director

Fetscherstraße 74
01307 Dresden

Location & Directions

Dresden
Airport Dresden
11 kilometer – approx. 20 minutes
Airport Leipzig/Halle
140 kilometer – approx. 1 hour 30 minutes
Airport Berlin-Tempelhof
190 kilometer – approx. 2 hours

Clinical Focus

  • Breast cancer (at the regional Breast Center)
  • Prostate cancer (Prostate Center)
  • Leukemia/stem cell transplants
  • Colorectal cancer (including liver metastases and hereditary syndromes)
  • Lung cancer
  • Brain tumors
  • Gynecologic tumors (in the gynecologic cancer center), skin tumors (in the skin tumor center)

About us

The Dresden University Cancer Center (UCC) is one of eleven "top oncological centers" of the Deutsche Krebshilfe e.V. in Germany. The UCC obtained this distinction as one of the first top centers in Germany, in 2007, after an international assessment.

The Dresden University Cancer Center was founded in 2003, jointly by the University Hospital and the Carl Gustav Carus Medical Faculty, as the Comprehensive Cancer Center for extensive interdisciplinary care of cancer patients, cancer research and teaching. The UCC has been certified in accordance with DIN EN ISO 9001:2000 since 2004.

Highly specialized expert doctors work together in every oncological discipline in the Dresden University Cancer Center, in order to provide the best possible, individually tailored, multi-disciplinary treatment
for cancer patients. Many specialists are not only experienced doctors, but are also active as university lecturers and in cancer research.
In this way, it is guaranteed that the most up-to-date knowledge is considered at every step, from diagnosis to treatment.

Diagnostic Services

  • Imaging: conventional X-rays, CT, MRI, PET/CT, ultrasound
  • Pathology
  • Genetics
  • Functional diagnosis

Therapeutic Services

  • Operations for special oncology in individual disciplines
  • Chemotherapy (systemic, local)
  • Radiation therapy (teletherapy and brachytherapy, stereotaxy), nuclear medicine therapy
  • Blood stem cell transplants
  • Radiological intervention
  • Pediatric oncology
  • Psycho-oncological care

Special Offers / Arrangements / Rooms

Inter-disciplinary outpatients and the tumor boards represent important platforms for patient care in the UCC. Inter-disciplinary outpatients offers a central place to go for patients before treatment, between treatment stages and during follow-up, and, as a control center, coordinates diagnosis and treatment, as well as the transitions between care from the referring G.P's and hospitalized treatment in the different departments of the University Hospital.
Individually recommended treatment is developed in the interdisciplinary tumor board of the UCC.